Renaissance Technologies’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Renaissance Technologies’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-56,534	Closed	-$263K	–	3470
2017 Q1	$263K	Buy	+56,534	New	+$328K	﹤0.01%	2944
2016 Q1	–	Sell	-397,600	Closed	-$2.25M	–	3627
2015 Q4	$2.25M	Buy	+397,600	New	+$2.42M	﹤0.01%	2030
2015 Q1	–	Sell	-162,095	Closed	-$494K	–	3434
2014 Q4	$494K	Buy	+162,095	New	+$479K	﹤0.01%	2431
2014 Q2	–	Sell	-197,390	Closed	-$1.05M	–	3088
2014 Q1	$1.05M	Sell	197,390 -14,130	-7%	-$79.2K	﹤0.01%	2061
2013 Q4	$1.17M	Buy	+211,520	New	+$912K	﹤0.01%	2000

Other funds holding SGYP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies's SGYP Position: Q2 2017 in Review

Renaissance Technologies sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 56,534 shares — an estimated $263K sold.

Renaissance Technologies first reported a position in SGYP in Q4 2013 and held it in 5 quarters. The position peaked at $2.25M in Q4 2015. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

Renaissance Technologies reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
Renaissance Technologies sold 56,534 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $263K.
Renaissance Technologies first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2013 and held it in 5 quarters.
Renaissance Technologies's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.25M in Q4 2015.
146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.